GB1252495A – – Google Patents
GB1252495A – – Google Patents
Info
Publication number
GB1252495A
GB1252495A
GB1252495DA
GB1252495A
GB 1252495 A
GB1252495 A
GB 1252495A
GB 1252495D A
GB1252495D A
GB 1252495DA
GB 1252495 A
GB1252495 A
GB 1252495A
Authority
GB
United Kingdom
Prior art keywords
jan
bacterial infections
compositions
infections
administration
Prior art date
1968-01-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1968-01-11
Filing date
1969-01-10
Publication date
1971-11-03
1969-01-10
Application filed
filed
Critical
1971-11-03
Publication of GB1252495A
publication
Critical
patent/GB1252495A/en
Status
Expired
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D211/40—Oxygen atoms
C07D211/44—Oxygen atoms attached in position 4
C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D211/40—Oxygen atoms
C07D211/42—Oxygen atoms attached in position 3 or 5
Abstract
1,252,495. Antibacterial compositions. STANLEY DRUG PRODUCTS, Inc. 10 Jan., 1969 [11 Jan., 1968], No. 1573/69. Heading A5B. Compositions for prophylactic treatment against bacterial infections, especially of staphylococcal and salmonella infections, comprise a carrier and the peptide homocarnosine (gamma-aminobutyrylhistidine) or a salt thereof. They may be in conventional forms for oral and parenteral administration. The invention further comprises the treatment of bacterial infections in non-human animals by the administration thereto of a composition or active compound according to the invention.
GB1252495D
1968-01-11
1969-01-10
Expired
GB1252495A
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US69700268A
1968-01-11
1968-01-11
US69702268A
1968-01-11
1968-01-11
Publications (1)
Publication Number
Publication Date
GB1252495A
true
GB1252495A
(en)
1971-11-03
Family
ID=27105913
Family Applications (2)
Application Number
Title
Priority Date
Filing Date
GB0099/69A
Expired
GB1189284A
(en)
1968-01-11
1969-01-08
Improvements in or relating to Diazotype Photoreproduction
GB1252495D
Expired
GB1252495A
(en)
1968-01-11
1969-01-10
Family Applications Before (1)
Application Number
Title
Priority Date
Filing Date
GB0099/69A
Expired
GB1189284A
(en)
1968-01-11
1969-01-08
Improvements in or relating to Diazotype Photoreproduction
Country Status (7)
Country
Link
US
(1)
US3497355A
(en)
CA
(1)
CA947656A
(en)
CH
(1)
CH490694A
(en)
DE
(2)
DE1900697A1
(en)
FR
(2)
FR2000156A1
(en)
GB
(2)
GB1189284A
(en)
NL
(2)
NL6900326A
(en)
Cited By (2)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
DE3424997A1
(en)
*
1983-07-06
1985-01-31
Nagai, Kineshirou
PHARMACEUTICAL PREPARATION FOR TREATING TUMORS AND USE OF HOMOCARNOSINE
GB2144039A
(en)
*
1983-07-27
1985-02-27
Kineshiro Nagai
Homocarnosine for treatment of inflammatory diseases
Families Citing this family (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4508728A
(en)
*
1984-05-24
1985-04-02
Kineshiro Nagai
Method of treating inflammatory diseases
Family Cites Families (9)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US2298444A
(en)
*
1940-10-15
1942-10-13
Eastman Kodak Co
Light sensitive diazotype material
NL235161A
(en)
*
1958-01-18
NL284911A
(en)
*
1961-11-11
BE629326A
(en)
*
1962-03-09
NL6400473A
(en)
*
1963-01-23
1964-07-24
US3203803A
(en)
*
1964-01-20
1965-08-31
Tecnifax Corp
Light-sensitive diazo hexafluoro-phosphate compositions
GB1106865A
(en)
*
1964-05-07
1968-03-20
Gen Aniline & Film Corp
Light-sensitive piperazinyl-benzene diazonium salts
US3379531A
(en)
*
1965-03-30
1968-04-23
Gen Aniline & Film Corp
Two-component heat developing diazotypes
US3424585A
(en)
*
1966-02-10
1969-01-28
Fairmont Chem Co Inc
Photosensitive diazotype materials
1968
1968-01-11
US
US697022A
patent/US3497355A/en
not_active
Expired – Lifetime
1968-12-31
CA
CA039,109A
patent/CA947656A/en
not_active
Expired
1969
1969-01-07
CH
CH12069A
patent/CH490694A/en
not_active
IP Right Cessation
1969-01-08
GB
GB0099/69A
patent/GB1189284A/en
not_active
Expired
1969-01-08
DE
DE19691900697
patent/DE1900697A1/en
active
Pending
1969-01-09
NL
NL6900326A
patent/NL6900326A/xx
unknown
1969-01-09
NL
NL6900367A
patent/NL6900367A/xx
unknown
1969-01-09
DE
DE19691900857
patent/DE1900857A1/en
active
Pending
1969-01-10
GB
GB1252495D
patent/GB1252495A/en
not_active
Expired
1969-01-10
FR
FR6900287A
patent/FR2000156A1/fr
not_active
Withdrawn
1969-01-13
FR
FR6900574A
patent/FR2000179A1/fr
not_active
Withdrawn
Cited By (2)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
DE3424997A1
(en)
*
1983-07-06
1985-01-31
Nagai, Kineshirou
PHARMACEUTICAL PREPARATION FOR TREATING TUMORS AND USE OF HOMOCARNOSINE
GB2144039A
(en)
*
1983-07-27
1985-02-27
Kineshiro Nagai
Homocarnosine for treatment of inflammatory diseases
Also Published As
Publication number
Publication date
NL6900367A
(en)
1969-07-15
DE1900857A1
(en)
1969-09-11
CA947656A
(en)
1974-05-21
DE1900697A1
(en)
1969-08-28
FR2000179A1
(en)
1969-08-29
NL6900326A
(en)
1969-07-15
US3497355A
(en)
1970-02-24
GB1189284A
(en)
1970-04-22
FR2000156A1
(en)
1969-08-29
CH490694A
(en)
1970-05-15
Similar Documents
Publication
Publication Date
Title
IE33167L
(en)
1969-12-28
Doxycycline solution
GB1388358A
(en)
1975-03-26
Taste-improving formulations of oral penicillins
GB1491503A
(en)
1977-11-09
Method of preventing and treating thrombosis
GB1252495A
(en)
1971-11-03
IL35334A
(en)
1974-01-14
Potentiation of antibiotics of the phosphonomycin series
GB1404614A
(en)
1975-09-03
Antibiotic a477 and process for preparation thereof
CA931960A
(en)
1973-08-14
Composes antiseborrheiques, procede de preparation de ces composes, compositions cosmetiques, shampooings et produits ingerables par voie orale contenant ces nouveauz composes
IL37703A
(en)
1975-05-22
N-benzyloxycarbonyl phenylalanine and derivatives thereof,boric acid complexes of said compounds and pharmaceutical compositions containing said n-benzyloxycarbonyl phenylalanine and derivatives thereof
AU471022B2
(en)
1976-04-08
Pharmaceutical compositions containing 3-hydroxy-5-pregnane 11, 2-dione
GB1291661A
(en)
1972-10-04
Sulphonylamino-pyrimidines
GB1321466A
(en)
1973-06-27
N-acetyl-6-amino-hexanoic acid derivative process for its production and pharmaceutical compositions containing the derivative
CA789017A
(en)
1968-07-02
.delta.8,9-ergolene-8-carboxylic acid amide derivatives
GB1243401A
(en)
1971-08-18
Pharmaceutical antiviral compositions
IE32384L
(en)
1969-04-04
Antibiotic veterinary composition
GB1312129A
(en)
1973-04-04
Antibiotic and process for preparing same
CA953715A
(en)
1974-08-27
N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same
GB1175590A
(en)
1969-12-23
Therapeutic Compositions
CA941375A
(en)
1974-02-05
1,2,4-oxidiazole salt, a process for the preparation thereof and pharmaceutical composition comprising same
GB1128833A
(en)
1968-10-02
Improvements in or relating to chlorhexidine complexes and to germicides containing them
AU451774B2
(en)
1972-06-15
Amino derived from 3,4-ethylenedioxy- -phenylacetonitrile and its non-toxic acid addition salts
GB1185616A
(en)
1970-03-25
2-Sulfanilamido-3-Halogeno-Pyridines
CA790063A
(en)
1968-07-16
.delta.8,9-ergolene-8-carboxylic acid amide derivatives
GB1250279A
(en)
1971-10-20
GB1200928A
(en)
1970-08-05
Medicine for the treatment of hemeralopia
GB1105468A
(en)
1968-03-06
Improvements in and relating to bactericidal medicines
Legal Events
Date
Code
Title
Description
1972-03-15
PS
Patent sealed [section 19, patents act 1949]
1982-08-04
PCNP
Patent ceased through non-payment of renewal fee
